- RESEARCH HIGHLIGHT
- 15 May 2026
The personalized treatment encourages the immune system to attack the tumours called glioblastomas.
Trending
- MMSDH facilitates ACSL4 propionylation to counteract ferroptosis upon hypoxia and impairs PDAC chemotherapy efficacy
- Development and preclinical evaluation of a decoy DLL4-encoding oncolytic HSV-1 for high-grade glioma
- ATR inhibition induces NF-κB-dependent immunogenicity in Merkel cell carcinoma independent of cGAS-STING
- Debating CAR T-Cell Therapy Vs Bispecifics at First Relapse in Myeloma
- A pro-inflammatory metastasis-associated macrophage subset induces tumor-promoting mesothelial cell conversion in ovarian cancer via IL-1α secretion
- Scientists find a way to break pancreatic cancer’s protective shield
- Perioperative Durvalumab Combo Boosts Survival in Resectable Gastric Cancer
- Targeting mitochondrial dysfunction and apoptosis in 5-fluorouracil–induced cardiotoxicity using kaempferol-mediated selenium nanoparticles
Sunday, September 13
